help button home button The Oncologist http://theoncologist.alphamedpress.org/misc/eLetters.shtml
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
The Oncologist, Vol. 10, No. 7, 471-479, August 2005; doi:10.1634/theoncologist.10-7-471
© 2005 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 A Review of the Diagnosis and Management of Male Breast Cancer
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giordano, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giordano, S. H.

A Review of the Diagnosis and Management of Male Breast Cancer

Sharon H. Giordano

Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA

Correspondence: Sharon H. Giordano, M.D., M.P.H., Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 424, Houston, Texas 77030, USA. Telephone: 713-792-2817; Fax: 713-794-4385; e-mail: sgiordan{at}mdanderson.org

Male breast cancer is an uncommon disease although the incidence has increased over the past 25 years. As with many other rare "orphan" diseases, male breast cancer is understudied. The rarity of the disease precludes prospective randomized clinical trials. In addition, few researchers and minimal funding have focused on breast cancer in men, but further work is clearly needed to better understand this disease. It shares many similarities with breast cancer in women; yet some clear differences have emerged. In this article, the latest information on the epidemiology, biology, and treatment of male breast cancer is reviewed.

Key Words. Male breast cancer • Epidemiology • Prognosis




This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
L. M. Arendt and L. A. Schuler
Prolactin Drives Estrogen Receptor-{alpha}-Dependent Ductal Expansion and Synergizes with Transforming Growth Factor-{alpha} to Induce Mammary Tumors in Males
Am. J. Pathol., January 1, 2008; 172(1): 194 - 202.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
I. Romao, E. Klass, P. J. Westenend, R. Storm, R. J. Oostenbroek, and G. D. Braunstein
Gynecomastia.
N. Engl. J. Med., December 20, 2007; 357(25): 2636 - 2636.
[Full Text] [PDF]

Home page
 The OncologistHome page
N. V. Dimitrov, P. Colucci, and S. Nagpal
Some Aspects of the Endocrine Profile and Management of Hormone-Dependent Male Breast Cancer
Oncologist, July 1, 2007; 12(7): 798 - 807.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
L. Chen, P. K. Chantra, L. H. Larsen, P. Barton, M. Rohitopakarn, E. Q. Zhu, and L. W. Bassett
Imaging characteristics of malignant lesions of the male breast.
RadioGraphics, July 1, 2006; 26(4): 993 - 1006.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS
http://theoncologist.alphamedpress.org/subscriptions/etoc.dtl

Copyright © 2005 by AlphaMed Press.